Window to Japan
With the success of household fuel cells “Ene farm” (エネファーム) of which 14 million units were sold since 2009, NEDO now aims at SOFCs in the several hundred kW class, for use by restaurants, hairdressing salons, small medical and welfare facilities etc. Market introduction by participants of the NEDO programm on SOFCs (2013 – 2017) […]
Based on the SACLA’s X-ray free electron laser facility (XFEL) which allows for continuous femtosecond crystal structure analysis of crystals only 7 – 10 μm in size, the structure of lysozyme could be resolved at 2,1 A precision without support of heavy metal substituted protein analogues, using a sulfor atom single-wavelength anomalous dispersion method (S-SAD). […]
In interviews and presentations at forums such as the Regenerative Medicine Innovation Forum in Osaka, representatives of Amano Enzyme have confirmed that they will provide sterile enzyme preparations for medical purposes by 2017 and invest in a sterile enzyme manufacturing facility of cGMP certification. Nikkei Biotech news release, November 27, 2015
In collaboration with CEA Saclay in France, the group of Yusuke NISHIYAMA has suceeded to detect metabolites in biological fluids, tissues and organs down to the µg level, using an improved detector and a sample tube for conventional NMR. RIKEN news release, November 26, 2015
49 self-luminous guide lights “E-SEG” were installed around Koku-koen station in Tokorozawa City, Saitama Prefecture. The cordless devices are based on an LED combined with a plastic solar cell storage battery. The test is aimed to test durability and performance under real-life conditions. NEDO news release, November 25, 2015
The team is under guidance of Tsugiya FUKUI and the objectives are to quantitatively assessing the risk of iPS cell-derived differentiated cells after transplantation Nikkei Biotech news release, November 20, 2015
The machine was codeveloped with the Kyoto University Institute of Frontier Medical Scineces. Pipetting is done by robotic technology, and 20 passages are possible oveer 60 days, maintaining an undifferentiated stage. Nikkei Biotech news release, November 20, 2015
During the 19th Annual Meeting ov the Japanese Vaccine Society Michiho OHARA announced having developed a recombinant vaccinia virus vaccine (LC16m8rVV-Flu HA) effective against H5N1 influenza. Nikkei Biotech news release, November 18, 2015
The center will focus on development and production of autologous bone marrow mesenchymal stem cells (MSC), for use in cerebral infarction and spinal cord surgery. The studies will include an endowed chair held by Professor Osamu HONMOU. Nipro news release, November 13, 2015
In an interview, RITE Chief Researcher Masayuki INUI disclosed that yields of resting cells of recombinant C. glutamicum surpassed already 140 g/L productivity of shikimic acid, which is over 50 % yield based on sugar feed. It is expected that yields can be further improved, e. g. in view of the production of “green phenol”, […]